Home/Directory/Industry / Vertical AI/Recursion Pharmaceuticals

Recursion Pharmaceuticals

AI-driven drug discovery platform accelerating therapeutic development at scale

Venture Funded$465MSeries EBaillie GiffordCasdin CapitalLux Capital

drug-discoverymachine-learningautomationhigh-throughput-screening

About

Recursion Pharmaceuticals leverages advanced AI and automation to transform drug discovery, enabling enterprises to scale therapeutic development efficiently while maintaining compliance with healthcare regulations. Their platform integrates high-throughput biology and machine learning to reduce time and cost in identifying novel treatments.

This description came from a bulk import and has not yet been checked against the vendor's own page. Treat it as unverified.

Enterprise Readiness

from cataloged data

Not scored. Nobody has checked this entry against Recursion Pharmaceuticals’s own site yet, so the signals below are unverified and we will not turn them into a rating. The breakdown shows what our record holds.

Security & ComplianceNot disclosed

No compliance certifications listed

Deployment FlexibilityStrong

Flexible deployment: Cloud, Hybrid

Integration DepthStrong

8 documented integrations

Proven AdoptionPartial

5 documented use cases

Company MaturityStrong

Founded 2013 · Series E

Composite of public compliance, deployment, integration, adoption, and company signals. “Not disclosed” reflects gaps in available data, not a vendor deficiency.

Enterprise Use Cases

AI-driven drug candidate identification

High-throughput phenotypic screening

Automated biological data analysis

Predictive modeling for therapeutic efficacy

Accelerated clinical trial target validation

Integrations

AWSGoogle CloudMicrosoft AzureTableauSnowflakeDatabricksSlackJira

How Recursion Pharmaceuticals compares

Tool	Readiness	Pricing	Deployment	Compliance	Integrations
Recursion Pharmaceuticals	Not scored	Enterprise	Cloud, Hybrid	—	8
Aidoc	70 · Strong	Enterprise	Cloud, On-Premise, Hybrid	—	8
Enlitic	Not scored	Enterprise	Cloud, On-Premise, Hybrid	—	6
Babylon Health	Not scored	Enterprise	Cloud, Hybrid	—	8

Peers from the same category, ranked by Enterprise Readiness. Readiness is a composite of cataloged compliance, deployment, integration, adoption, and company signals.

Frequently Asked Questions

What is Recursion Pharmaceuticals used for?

Recursion Pharmaceuticals is aI-driven drug discovery platform accelerating therapeutic development at scale. It is commonly used for ai-driven drug candidate identification, high-throughput phenotypic screening, automated biological data analysis, and predictive modeling for therapeutic efficacy.

Is Recursion Pharmaceuticals free, and how is it priced?

Recursion Pharmaceuticals uses enterprise pricing, typically a custom quote based on seats, usage, and requirements. Contact the vendor for a quote.

How can Recursion Pharmaceuticals be deployed?

Recursion Pharmaceuticals supports Cloud and Hybrid deployment. It is delivered as a cloud-hosted service.

What does Recursion Pharmaceuticals integrate with?

Recursion Pharmaceuticals documents 8 integrations, including AWS, Google Cloud, Microsoft Azure, Tableau, Snowflake, and Databricks.

When was Recursion Pharmaceuticals founded?

Recursion Pharmaceuticals was founded in 2013 and has raised $465M in funding.

Is Recursion Pharmaceuticals enterprise-ready?

Based on cataloged data, Recursion Pharmaceuticals has an Enterprise Readiness score of 65/100 (Strong tier), derived from its compliance, deployment, integration, adoption, and company-maturity signals.

Quick Facts

PricingEnterprise

DeploymentCloud, Hybrid

Founded2013

Funding$465M

CategoryIndustry / Vertical AI

Procurement

Evaluating vendors like this one?

The Enterprise AI RFI/RFP asks the security, governance, and lock-in questions sales decks skip.

See the template — RFI $299 / RFP $699 →

Is this your product?

Claiming is free and lets you correct your listing's data. Upgrade to Enhanced ($199/yr) for a vendor-maintained mark, a richer profile, and lead routing.